Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
2.710
-0.010 (-0.37%)
Nov 21, 2024, 4:00 PM EST - Market closed
Poseida Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 264 | 321 | 456 | 426 | 678 | - | |
| Market Cap Growth | 22.53% | -29.47% | 7.02% | -37.23% | - | - | |
| Enterprise Value | 117 | 169 | 267 | 288 | 396 | - | |
| Last Close Price | 2.72 | 3.36 | 5.30 | 6.81 | 10.97 | - | |
| PS Ratio | 1.74 | 4.97 | 3.49 | 13.63 | - | - | |
| PB Ratio | 3.04 | 3.10 | 2.43 | 2.72 | 2.59 | - | |
| P/TBV Ratio | 3.40 | 3.27 | 2.50 | 2.83 | 2.64 | - | |
| EV/Sales Ratio | 0.78 | 2.61 | 2.05 | 9.22 | - | - | |
| Debt / Equity Ratio | 0.95 | 0.82 | 0.47 | 0.39 | 0.24 | 0.43 | |
| Asset Turnover | 0.51 | 0.21 | 0.42 | 0.10 | - | - | |
| Quick Ratio | 3.14 | 3.10 | 5.41 | 4.76 | 10.30 | 5.73 | |
| Current Ratio | 3.20 | 3.18 | 5.54 | 4.94 | 10.46 | 5.82 | |
| Return on Equity (ROE) | -57.63% | -84.75% | -37.23% | -59.77% | -77.27% | -242.83% | |
| Return on Assets (ROA) | -13.11% | -25.87% | -12.06% | -27.59% | -30.51% | -51.30% | |
| Return on Capital (ROIC) | -20.57% | -34.78% | -15.18% | -32.66% | -36.84% | -80.79% | |
| Earnings Yield | -22.42% | -38.42% | -14.05% | -29.36% | -19.14% | - | |
| FCF Yield | -6.32% | -29.64% | -6.74% | -24.71% | -19.20% | - | |
| Buyback Yield / Dilution | -9.93% | -25.34% | -15.61% | -72.89% | -185.27% | -3.57% | |
| Total Shareholder Return | -9.93% | -25.34% | -15.61% | -72.89% | -185.27% | -3.57% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.